Accelerate Diagnostics reported 897K in Gross Profit on Sales for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Becton, Dickinson and BDX:US $ 2161M 85M
Bio Rad Laboratories BIO:US $ 402.7M 21.83M
Bruker BRKR:US $ 280.6M 1.9M
Danaher DHR:US $ 4359M 38M
Genmark Diagnostics GNMK:US $ 19.4M 2.86M
Hologic HOLX:US $ 701.6M 384.2M
Illumina ILMN:US $ 802M 38M
Luminex LMNX:US $ 66.46M 2.02M
Meridian Bioscience VIVO:US $ 37.11M 20.66M
Myriad Genetics MYGN:US $ 135.7M 12.9M
Nanostring Technologies NSTG:US $ 18.38M 2.39M
Oxford Immunotec Global OXFD:US $ 14.86M 11.19M
Pacific Biosciences Of California PACB:US $ 13.75M 0.78M
Perkinelmer PKI:US $ 685.19M 99.95M
Quidel QDEL:US $ 106.19M 195.77M
Thermo Fisher Scientific TMO:US $ 4797M 273M